孕产妇免疫接种改善HIV暴露婴儿健康
本综述聚焦HIV暴露未感染(HEU)婴儿感染风险增高的问题,评估孕期接种疫苗在HIV感染女性中的免疫原性与有效性证据。在11种推荐、考虑或研究中用于孕期的疫苗里,仅3种在HIV感染女性中研究过。现有证据提示HIV感染限制多种疫苗的免疫原性,使HEU婴儿出生后数月更易感,但孕产妇免疫是否降低其感染相关患病与死亡仍未知。
要点
- HIV感染可能降低孕期接种疫苗的免疫原性,影响HEU婴儿保护。
- 仅3/11种孕期相关疫苗在HIV感染女性中研究过。
- 孕产妇免疫能否降低HEU婴儿感染相关患病与死亡尚不明确。
核心结论
- 现有证据提示HIV感染限制多种孕期疫苗的免疫原性,使HEU婴儿出生后数月更易感。
- 孕产妇免疫是否降低HEU儿童感染相关患病与死亡仍未知。
研究设计与样本
- 综述纳入11种孕期推荐、考虑或研究中用于常规或风险接种的疫苗。
主要发现
- 11种疫苗中仅3种在HIV感染女性中研究过。
- 现有证据提示HIV感染限制多种疫苗的免疫原性。
- HEU婴儿在出生后数月更易发生感染。
局限性
- 多数孕期相关疫苗在HIV感染女性中缺乏研究。
- 孕产妇免疫对HEU儿童感染相关患病与死亡的影响缺乏证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HIV-exposed but uninfected (HEU) infants are at an increased risk of many infectious diseases that can contribute to the high mortality seen among HEU children. Maternal immunisation could be a promising strategy to reduce infections in HEU infants. However, very little research has explored the effect of HIV on the immunogenicity and effectiveness of vaccines given during pregnancy. We review the available evidence on maternal immunisation among women living with HIV (WLWH) for all vaccines recommended, considered, or being investigated for routine or risk-based use during pregnancy. Of the 11 vaccines included, only three have been investigated in WLWH. Available evidence suggests that maternal HIV infection limits the immunogenicity of several vaccines, leaving HEU infants more susceptible to infection during their first few months of life. Whether maternal immunisation reduces the infectious morbidity and mortality associated with infectious diseases in HEU children remains unknown. We conclude the Review by identifying future research priorities.
引用
- Bengtson AM, Sanfilippo AM, Hughes BL, et al. Maternal immunisation to improve the health of HIV-exposed infants. Lancet Infect Dis. 2018. PMID: 30529212. doi:10.1016/S1473-3099(18)30545-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。